Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Read-outs for HBsAg/AS Vaccine in Healthy Adults
NCT01777295Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- May 2016
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK2231392A in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Concentrations of Cytokines and Chemokines at Day 187. Started Feb 2013; status: completed.
02
Drugs
GSK2231392A
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01777295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777295.